Attention-Deficit/Hyperactivity Disorder (ADHD) is the most common childhood neurodevelopmental disorder, affecting approximately 6–10% of Australian children. Without timely treatment, ADHD can lead to lifelong impairment, including increased risk of substance use, poorer educational and employment outcomes, and reduced social and emotional wellbeing.
Within the Healthy North Coast region (Northern NSW and Mid North Coast Local Health Districts), lengthy wait times for paediatric ADHD assessments have created significant access inequities, particularly for vulnerable families. These delays in diagnosis and treatment increase the complexity of ADHD management and place added pressure on specialist services.
The Henry Review (2020) identified inefficiencies in specialist-led stimulant prescribing and recommended alternative care models. In response, the NSW Ministry of Health introduced key reforms:
These reforms aim to reduce wait times, improve access to assessment and treatment, and strengthen ADHD care delivery across NSW.
On 1 November 2024, Northern NSW public paediatric clinics transitioned to a co-management model for stable ADHD patients, with Mid North Coast clinics following in November 2025.
Under this model:
• Paediatricians confirm diagnosis, initiate treatment, and provide detailed medication and monitoring plans to the patient’s GP.
• GPs assume responsibility for ongoing prescribing, review, and monitoring in accordance with the specialist’s recommendations.
• Both clinicians ensure prescribing remains under a single prescriber at any given time.
The ADHD CNC Co-Management Coordinator, Bel Davis (nnswlhd-adhd@health.nsw.gov.au | mnclhd-adhd@health.nsw.gov.au, 0427 940 980), plays a pivotal role in supporting GPs to safely co-manage ADHD patients. The role includes GP education, facilitation of communication between primary and specialist care, transition planning to adult services, and oversight of clinical initiatives aimed at reducing wait times and improving outcomes.
Project Components
1. GP Training and Support
– Education sessions on ADHD assessment, prescribing, medication titration, SafeScript use, and PBS authority processes.
– Access to HealthPathways for localised clinical guidelines and referral pathways.
– Ongoing collaboration between GPs, paediatricians, and the ADHD coordinator.
– Promotion of appropriate MBS item use to ensure sustainability.
2. Co-Management of ADHD Care
– Shared care between GPs and specialists for stable ADHD patients.
– Regular medication reviews, monitoring, and documentation of treatment response.
– Integration of non-pharmacological interventions, including behavioural therapies, school supports, and allied health input.
3. Improving Access and Reducing Wait Times
– Reduced demand on specialist paediatric services by shifting stable management to primary care.
– Expanded GP and nurse roles, enhancing professional development and workforce capacity.
– Timely follow-up and continuity of care for children with complex needs.
Supporting Resources
HealthPathways
• ADHD in Children and Adolescents
• ADHD Medication Co-management for Children and Adolescents
• Non-Acute Paediatric Assessment
Useful Links
Continuation Prescriber – NSW Health
https://www.health.nsw.gov.au/pharmaceutical/doctors/Pages/adhd-management-prescribes.aspx
Explains the new Continuation Prescriber arrangements, eligibility, and authority requirements for GPs continuing ADHD medication prescribing.
SafeScript NSW Education and Training – NSW Health
https://www.health.nsw.gov.au/pharmaceutical/safescript/practitioners/Pages/education-training.aspx
Provides practitioner training and resources for SafeScript NSW, the real-time prescription monitoring system.
Clinical Guidelines – ADHD (AADPA)
https://aadpa.com.au
Access the Australian Evidence-Based Clinical Practice Guideline for ADHD, detailing national standards for assessment and treatment across the lifespan.
NSW Health / University of Sydney – Brain and Mind Centre ADHD Training
https://short-courses.sydney.edu.au/class/ADHD-1
An online e-learning course developed by the Brain and Mind Centre, funded by NSW Health, to upskill primary care practitioners in ADHD management.
Covers diagnostic pathways, pharmacological and non-pharmacological management, and collaborative care models. The first 500 enrolments are free.
Medication Information Sheets – Choice and Medication (Hunter New England Health)
https://www.choiceandmedication.org/hunternewengland/printable-leaflets/
Download clear, printable information sheets for patients and families explaining ADHD medications, side effects, and safe use.
Agency for Clinical Innovation (ACI) – ADHD in General Practice
https://aci.health.nsw.gov.au/projects/adhd-in-general-practice
Outlines NSW system-wide initiatives supporting general practice involvement in ADHD management.
Therapeutic Goods Administration (TGA) – Medication Shortages
https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-methylphenidate-hydrochloride-products
Provides current updates on ADHD medication shortages, expected resupply timelines, and prescriber guidance.
Autofills
Pre-filled clinical note templates designed for integration into practice software, enabling GPs and practice staff to efficiently document ADHD co-management reviews. These can be adapted to individual practice workflows.
Please contact your HNC Regional Manager or the ADHD Co-Management Co-ordinator on 0427940980 or at NNSWLHD-ADHD@health.nsw.gov.au or mnclhd-adhd@health.nsw.gov.au for further information